Found 6 matching trials
Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis PHASE3 Safety and Efficacy study of AVT04 (Alvotech Biosimilar to Ustekinumab), in...
Show More Location
North Estonia Medical Centre
Learn More & Join Trial
Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects PHASE1 It is a randomized, double-blinded, single-dose, 3-arm parallel, comparativ...
Show More Location
The First Hospital of Jilin University
Learn More & Join Trial
Pharmacokinetics, Safety and Tolerability Study of AVT04 to EU Approved and US Licensed Stelara (Ustekinumab) PHASE1 Protocol Title:
A Phase 1, first-in-human, randomized, double-blind, singl...
Show More Learn More & Join Trial
Bioequivalence Phase I Study of BFI-751 Compared With EU and US-STELARA® in Healthy Adults PHASE1 BFI-751 is being developed by BioFactura Australia Pty Ltd as a biosimilar ...
Show More Learn More & Join Trial
Comparative Study of BAT2206 With Stelara® in Patients With Moderate to Severe Plaque Psoriasis PHASE3 This study is a multicenter, randomized, double-blind, parallel-arm, Phase ...
Show More Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Learn More & Join Trial
A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to European Union (EU) Sourced Stelara and United States of America (US) Sourced Stelara in Healthy Subjects PHASE1 This is a randomised, double-blind, three-arm, parallel group, single-dose ...
Show More Learn More & Join Trial